Treatment Comparison

TEVAR vs Open Aortic Repair: Endovascular or Surgery for Aortic Disease?.

Sandeep M. Patel, MD
Sandeep M. Patel, MD
13 min read · Updated 2026-03-07

Thoracic aortic disease — including aneurysms, dissections, traumatic injuries, and penetrating ulcers — has historically required major open surgical repair through thoracotomy or sternotomy with hypothermic circulatory arrest. Thoracic endovascular aortic repair (TEVAR) introduced a catheter-based alternative in the early 2000s, deploying a covered stent graft within the diseased aorta through the femoral artery. TEVAR has rapidly become the preferred approach for descending thoracic aortic pathology in many situations. However, the choice between TEVAR and open repair is not straightforward. Anatomy, pathology location, patient age, connective tissue disorders, and the need for arch or root involvement all influence the decision. TEVAR is ideal for the descending thoracic aorta but cannot address the ascending aorta or aortic root — open surgery remains mandatory for these regions. Even in the descending aorta, long-term durability concerns, endoleak rates, and the need for reintervention distinguish TEVAR from the proven durability of open repair. This decision requires specialized expertise in both open aortic surgery and endovascular techniques — the hallmark of a comprehensive aortic program.

Head-to-head comparison.

Option A

TEVAR

Thoracic Endovascular Aortic Repair

TEVAR deploys a covered stent graft within the thoracic aorta via catheter access through the femoral artery. The graft excludes the diseased segment from blood flow, allowing it to thrombose and remodel over time. The procedure is performed under fluoroscopic guidance, typically with general or regional anesthesia. Modern devices offer improved conformability and branch/fenestrated options for arch and visceral involvement.

Advantages
Minimally invasive — no thoracotomy or sternotomy
Avoids aortic cross-clamping and circulatory arrest
Dramatically lower perioperative mortality (2-5% vs 8-15% for open)
Shorter hospital stay and ICU time
Lower spinal cord ischemia risk for focal descending pathology
Applicable to high-risk patients unfit for open repair
Limitations
Limited to descending thoracic aorta — cannot address ascending aorta or root
Endoleak risk (10-15%) requiring surveillance and potential reintervention
Long-term durability uncertain — graft migration, device fatigue possible
Requires lifelong CT surveillance with radiation and contrast exposure
Anatomy-dependent: requires adequate landing zones (2+ cm healthy aorta)
Not appropriate for connective tissue disorders (Marfan, Loeys-Dietz) in most cases
Best For
Descending thoracic aortic aneurysms with favorable anatomy
Acute complicated Type B aortic dissection
Traumatic aortic injury
High-risk patients not candidates for open repair
Penetrating aortic ulcers and intramural hematomas of descending aorta
2-5%
30-Day Mortality
10-15%
Endoleak Rate
3-5 days
Hospital Stay
Option B

Open Aortic Repair

Open Surgical Thoracic Aortic Repair

Open thoracic aortic repair involves replacing the diseased aortic segment with a prosthetic Dacron graft through a thoracotomy (descending aorta) or sternotomy (ascending/arch). For ascending and arch repairs, deep hypothermic circulatory arrest (DHCA) or moderate hypothermia with antegrade cerebral perfusion is used to protect the brain during periods of circulatory interruption. It remains the only option for ascending aortic and aortic root pathology.

Advantages
Only option for ascending aorta, aortic root, and complex arch pathology
Proven long-term durability — Dacron grafts last a lifetime
No endoleak risk — no need for lifelong CT surveillance
Definitive treatment for connective tissue disorders (Marfan, Loeys-Dietz)
Can address concurrent pathology (aortic root, valve, coronary reimplantation)
Lower reintervention rate compared to TEVAR over time
Limitations
Major surgery with significant morbidity
Higher perioperative mortality (5-15% depending on extent and urgency)
Thoracotomy pain and prolonged recovery
Spinal cord ischemia risk for extensive descending/thoracoabdominal repair (5-10%)
Requires circulatory arrest for arch operations — stroke risk
Prolonged ICU and hospital stay (7-14+ days)
Best For
Ascending aortic aneurysm and dissection (Type A)
Aortic arch pathology requiring total arch replacement
Connective tissue disorders (Marfan, Loeys-Dietz, Ehlers-Danlos)
Young patients where lifetime durability is critical
Complex aortic root pathology requiring Bentall or valve-sparing root replacement
5-15%
30-Day Mortality
Lifetime
Graft Durability
7-14 days
Hospital Stay
Clinical Evidence

Key clinical trials.

2008
VALOR
TEVAR vs medical management for descending thoracic aneurysms: TEVAR significantly reduced aneurysm-related mortality and had lower perioperative morbidity than historical open repair controls.
2013
INSTEAD-XL
TEVAR for uncomplicated Type B dissection: TEVAR improved aorta-specific survival and delayed disease progression at 5 years compared to optimal medical therapy. Changed management paradigm for subacute uncomplicated Type B dissection.
2015
ADSORB
TEVAR for acute uncomplicated Type B dissection: TEVAR promoted favorable aortic remodeling (false lumen thrombosis) compared to medical therapy alone at 1 year.
2016
Coselli et al. (Baylor)
Open thoracoabdominal aortic repair: 30-day mortality 5.0%, stroke 2.7%, paraplegia 3.4% in high-volume center. Demonstrated that open repair remains safe in expert hands with spinal cord protection protocols.
Practice Guidelines

What the guidelines say.

The 2022 ACC/AHA Guideline for Aortic Disease recommends TEVAR for descending thoracic aneurysms meeting size criteria (>5.5 cm or rapid growth) with favorable anatomy (Class I). Open repair is recommended for ascending aortic aneurysms >5.5 cm (Class I), or >5.0 cm in the presence of risk factors. For acute Type A dissection, emergency open surgical repair is mandatory (Class I). For complicated Type B dissection, TEVAR is recommended (Class I). Management should occur at experienced aortic centers.

Heart Team Approach

Why the Heart Team matters.

Aortic disease management requires a specialized team — often called an "Aortic Team" — comprising cardiac surgeons with open aortic expertise, endovascular specialists, and imaging experts. The decision between TEVAR and open repair depends on precise anatomical assessment (landing zones, branch vessel involvement, connective tissue status), pathology type, and patient risk profile. WhiteGloveMD provides this multidisciplinary aortic evaluation, helping patients understand whether endovascular or open repair offers the best risk-benefit profile.

The Bottom Line

TEVAR has transformed the treatment of descending thoracic aortic disease, offering lower perioperative mortality and faster recovery. However, open repair remains essential for ascending aortic disease, connective tissue disorders, and complex arch pathology. Long-term durability and surveillance requirements of TEVAR must be weighed against the proven permanence of open repair. The decision should be made at an experienced aortic center capable of both approaches.

Frequently asked questions.

Can a thoracic aortic aneurysm always be treated with a stent?

No. TEVAR is limited to the descending thoracic aorta with adequate healthy landing zones. Ascending aortic aneurysms, arch aneurysms without suitable anatomy, and patients with connective tissue disorders generally require open surgical repair.

What is an endoleak?

An endoleak is persistent blood flow around or through a stent graft, pressurizing the aneurysm sac. Type I (attachment site leak) and Type III (graft defect) require reintervention. Type II (branch vessel backflow) is often observed. Endoleaks are the primary reason TEVAR patients need lifelong CT surveillance.

Is emergency surgery always needed for aortic dissection?

Type A dissection (involving the ascending aorta) requires emergency open surgery — this is one of the true surgical emergencies in medicine. Type B dissection (limited to the descending aorta) is initially managed with blood pressure control and pain management, with TEVAR reserved for complications (malperfusion, rupture, rapid expansion).

Stay informed.
Expert cardiac surgery insights from the WhiteGloveMD Heart Team, delivered to your inbox.
No spam. Unsubscribe anytime. HIPAA-compliant.

Not sure which option is right for you?

Our Heart Team evaluates your specific anatomy, risk factors, and goals to recommend the best approach. 48-hour turnaround.

Get Your Second Opinion Risk Calculator
Related Conditions
Thoracic Aortic AneurysmAortic Dissection
Related Comparisons
Bentall Vs Valve SparingOpen Vs Minimally Invasive